Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Paula Polzer"'
1
An indirect comparison of long‐term efficacy of every‐2‐week dosing vs. recommended dosing of ixekizumab in patients who had static Physician's Global Assessment > 1 at week 12
Autor: Melinda Gooderham, O.O. Osuntokun, Paula Polzer, Catherine Maari, Lynda Spelman, Matthias Augustin, L. Zhang, Keiichi Yamanaka, Kim Papp, A. Cauthen
Publikováno v: British Journal of Dermatology. 183:52-59
Background Long-term efficacy and safety of ixekizumab [160 mg at week 0, then 80 mg every 2 weeks (Q2W) for 12 weeks, followed by every 4 weeks (Q4W) thereafter (i.e. Q2W/Q4W), which is the labelled psoriasis dosing where approved, except in Japan]
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bb238dd1416a75c1b931e88cfa829f5
https://doi.org/10.1111/bjd.18550
Zobrazit plný text záznamu
2
Ixekizumab—An Effective and Safe Treatment for Moderate-to-Severe Plaque Psoriasis in Patients Previously Treated With Other IL-17 Inhibitors: Results From IXORA-P
Autor: John Sullivan, Yayoi Tada, L. Zhang, Kim Papp, Andrew Blauvelt, Chi-Ho Hong, Lotus Mallbris, Paula Polzer
Publikováno v: Journal of Psoriasis and Psoriatic Arthritis. 4:180-185
Background: The impact of treatment with interleukin 17 (IL-17) inhibitors on the efficacy of subsequent IL-17 inhibitor therapy is unknown. Objective: To evaluate the impact of previous treatment with IL-17 inhibitors on the 52-week efficacy of ixek
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::aaa265575121dc3c3f0e5d7a71709a96
https://doi.org/10.1177/2475530319867095
Zobrazit plný text záznamu
3
Efficacy and safety of continuous every-2-week dosing of ixekizumab over 52 weeks in patients with moderate-to-severe plaque psoriasis in a randomized phase III trial (IXORA-P)
Autor: Melinda Gooderham, Kim Papp, Paula Polzer, Andrew Blauvelt, L. Zhang, Noah Agada, Richard G. Langley, Peter Foley, C Mallinckrodt
Publikováno v: The British journal of dermatology. 178(6)
Background Ixekizumab is an interleukin-17A antagonist approved for treatment of moderate-to-severe plaque psoriasis with a recommended 160-mg starting dose, then 80 mg every 2 weeks (Q2W) to week 12, and every 4 weeks (Q4W) thereafter. Objective To
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a8292dc3c728f47ab863c09ed842f3e
https://pubmed.ncbi.nlm.nih.gov/29897126
Zobrazit plný text záznamu
4
Clinical and Demographic Correlates of Ejaculatory Dysfunctions Other Than Premature Ejaculation: A Prospective, Observational Study
Autor: Darius A. Paduch, Abraham Morgentaler, Craig F. Donatucci, Paula Polzer, Ankur B. Patel, Stanley E. Althof, Shezhad Basaria, Xiao Ni
Publikováno v: The Journal of Sexual Medicine. 12:2276-2286
Introduction Ejaculatory dysfunctions other than premature ejaculation are commonly encountered in specialized clinics; however, their characterization in community-dwelling men is lacking. Aim The aim of this study was to evaluate the prevalence, se
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34a5a596a2e813afd5eab9b3a1f56feb
https://doi.org/10.1111/jsm.13027
Zobrazit plný text záznamu
5
Delayed Ejaculation and Associated Complaints: Relationship to Ejaculation Times and Serum Testosterone Levels
Autor: Shehzad Basaria, Ankur B. Patel, Craig F. Donatucci, Xiao Ni, Alexander Bolyakov, Paula Polzer, Abraham Morgentaler, Stanley E. Althof
Publikováno v: The journal of sexual medicine. 14(9)
Background Although delayed ejaculation (DE) is typically characterized as a persistently longer than anticipated or desired time to ejaculation (or orgasm) during sexual activity, a timing-based definition of DE and its association with serum testos
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0aed7e6fc938403928e05461515a619
https://pubmed.ncbi.nlm.nih.gov/28807505
Zobrazit plný text záznamu
6
Effects of 12 weeks of tadalafil treatment on ejaculatory and orgasmic dysfunction and sexual satisfaction in patients with mild to severe erectile dysfunction: integrated analysis of 17 placebo-controlled studies
Autor: Darius A. Paduch, Paula Polzer, Steven Watts, Alexander Bolyakov
Publikováno v: BJU International. 111:334-343
What's known on the subject? and What does the study add? Disorders of ejaculation and orgasm are common, even in men with only mild erectile dysfunction (ED). Treatment with the phosphodiesterase type-5 inhibitor tadalafil was associated with improv
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1a84014faef6cb561840d4b7ddde4fd5
https://doi.org/10.1111/j.1464-410x.2012.11656.x
Zobrazit plný text záznamu
7
Testosterone Replacement in Androgen-Deficient Men With Ejaculatory Dysfunction: A Randomized Controlled Trial
Autor: Xiao Ni, Paula Polzer, Shehzad Basaria, Darius A. Paduch
Publikováno v: The Journal of clinical endocrinology and metabolism. 100(8)
Low T levels have been associated with ejaculatory dysfunction (EjD) in cross-sectional studies; however, the efficacy of T replacement in improving EjD has not been studied in a randomized controlled trial.To evaluate the efficacy of T replacement i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e4187b4810ddac9cfbd2a912a4122c1
https://pubmed.ncbi.nlm.nih.gov/26158605
Zobrazit plný text záznamu
8
Effect of deodorant and antiperspirant use and presence or absence of axillary hair on absorption of testosterone 2% solution applied to men's axillae
Autor: David S. Small, Paula Polzer, Malcolm I. Mitchell, Xiao Ni, Richard Vart, Darlene K. Satonin
Publikováno v: The journal of sexual medicine. 11(11)
Introduction Testosterone 2% solution is applied to axillae and is indicated for testosterone replacement therapy in males deficient in endogenous testosterone. Aim This open‐label crossover study evaluated the effect of deodorant/antiperspirant us
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1035929962f034eab2502eb82124b2ce
https://pubmed.ncbi.nlm.nih.gov/25617293
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje